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1. Introduction 
There is a general agreement hat myelin from 
central nervous system has a relatively simple protein 
composition, which makes it an excellent material for 
protein-lipid interaction studies in a membrane. Three 
main protein types have been described: basic pro- 
teins, proteolipid proteins and acidic Wolfgram pro- 
teolipid proteins (see ref. [l] for review). The distri- 
bution ratio between these proteins is variable 
depending on the procedures used [2-51 and 
animal species examined [2,6,7]. 
In human myelin, most work has been devoted to 
the unique basic protein [8-lo], and a sequence has 
been published [ 11 ,121. To our knowledge no com- 
parable information is available for the other pro- 
teins; so, during the course of the sequence study of 
the major rat brain myelin proteolipid P7 protein 
[ 131, we also decided to elucidate the primary 
structure of the corresponding human protein. This 
was done in order to provide information of possible 
homology in protein sequence of the proteolipid 
apoprotein during evolution. In the present paper, 
we present results concerning the amino acid compo- 
sition and the sequence of the first 20 amino acids of 
the N-terminal moiety. 
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2. Material and methods 
Myelin was isolated from human white matter by 
a modification of the method of Kurihara et al. 
[ 141 using an initial 5% homogenate. Human material 
was obtained from a body without any neuropatho- 
logical signs within 3 hr after death. Up to 8.5 g of 
dry weight myelin was prepared starting with 195 g 
of white matter from one adult brain. 
The procedures for preparation of the myelin 
proteolipids were those described in detail in previous 
works [ 5,131. The preparative SDS-gel electropho- 
resis of W apoprotein was done in an apparatus 
similar to that described by Waehneldt [ 151, entirely 
automated [ 131. The recuperation of the native apo- 
protein from fractions containing pure P7 was carried 
out by acidification with acetic acid extraction with 
diethyl ether as mentioned earlier [ 131. The protein 
precipitate was collected, dissolved in 98% formic 
acid and dialyzed during 48 hr against acetic acid 
solutions of decreasing molarity. Finally the protein 
was obtained by lyophilisation. 
The other analytical methods used, for amino acid 
determination, oxidation by performic acid, auto- 
mated Edman degradation with a Socosi sequencer and 
digestion by carboxypeptidase A, were identical to 
those indicated in a foregoing work [ 131. 
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3. Results 
The purity of the myelin was checked by electron 
microscopy. Fig. 1 shows the electrophoretic pattern 
of rat and human myelin proteins after electropho- 
resis on polyacrylamide gels in the presence of SDS. 
Proteolipids P7 and P8M in both species have identical 
migration rates, indicating very close molecular weights. 
Amino acid analyses have been performed on pu- 
rified human P7 preparations using three hydrolysis 
times (table 1); the nearest integer obtained was 
Fig. 1. SDS-polyacrylamide gel electrophoresis of the individ- 
ual human myelin proteolipids P7 (gel C) and P8M (gel D) 
isolated by a preparative scale method in comparison to total 
myelin proteins from human (gel B) and rat (gel A) brain. 
The homogeneity of each isolated proteolipid is indicated 
by the same relative mobilities on SDS gels as those observed 
in the original myelin preparation. AB C D 
Table 1 
Amino acid analysis of the major human brain myelin proteolipid P7 
apoprotein: residues/mole of mol. wt. 23 500. Comparison with the rat brain 
myelin proteolipid P7 
Amino acid Human brain Rat brain nearest 
integer [ 131 
Time of hydrolysis Nearest 
integer 
18 hr* 48 hr 72 hr 
AsP 
Thr 
Ser 
Glu 
pro 
CLY 
Ala 
Val 
(CYS-) 
Met 
Be 
Leu 
TYr 
Phe 
Trp** 
LYS 
His 
Arg 
10.2 9.1 9.0 
16.1 15.1 14.4 
12.4 10.5 10.0 
13.0 12.9 13.1 
6.2 5.8 5.4 
21.4 21.7 22.0 
24.0 24.0 24.0 
14.3 15.0 15.9 
8.3 8.0 8.0 
3.0 2.7 2.9 
10.5 10.9 11.4 
22.3 22.9 23.1 
9.7 9.5 10.0 
16.9 16.1 16.3 
8.9 9.6 9.7 
5.7 5.2 5.2 
5.4 5.9 5.4 
11 11 
17 17 
12-13 12 
13 13 
6 6 
22 22 
24 24 
16-17 17 
8-9 8 
3 3 
12 12 
23-24 24. 
10 10 
17 17 
2 2 
10 10 
5-6 5 
6 6 
Total 217-222 219 
*Residues per mole calculated on the basis of 24 residues of Ala. 
**Characterized following the procedure of Spies and Chambers [ 201. 
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Table 2 
N-terminal sequence of the major human brain myeIin 
proteolipid P7 apoprotein determined with a Sequencer 
(For experimental details, see ref. [ 131) 
I Gly-Leu-Leu-Glu-Cys-Cys-AIa-Arg-Cys-Leu- 
II Val-Gly-Ala-Pro-Phe-AIa-X-Leu-Val-AIa- 
20 
X, unidentified amino acid. 
compared with that of rat brain. No significant dif- 
ferences can be observed. 
The proposed N-terminal sequence of P7 apopro- 
tein, after performic oxidation, is given in table 2; 
it corroborates the sequence found by studying the 
P7 of rat brain [ 131. Until now, there exist some dif- 
ficulties in identifying the amino acid in position 17. 
Treatment of the oxidized apoprotein with carboxy- 
peptidase A released only phenylalanine, identified 
by using the amino acid analyzer. 
4. Discussion 
The methodology developed in the course of a 
>revious tudy [ 131 led us to examine the amino acid 
composition and a part of the N-terminal sequence of 
human myelin P7 proteolipid apoprotein obtained in 
pure state as checked by gel electrophoresis (fig. 1). 
Gagnon et al. [ 161 have also claimed the isolation of 
a highly purified human myelin protein with similar 
properties to that of proteolipids. Glycine was the 
N-terminal amino acid reported, but the authors 
concluded that it was a glycoprotein since some 
carbohydrates are present in appreciable amounts. 
This conclusion is not in accordance with other work- 
ers using classical proteolipids [ 171, so that we feel 
that Gagnon’s preparation might be rather an aggre- 
gation of denaturated proteolipid with some other 
minor proteins of myelinic origin. Other studies on 
unpurified proteolipid protein preparations from 
myelin of human and calf brain have also shown that 
glycine was the most abundant N-terminal amino acid 
[ 181. Finally, Whikehart and Lees [ 191 have found 
that the major N-terminal residue of white matter and 
myelin proteolipid was glycine with glutamic acid (or 
glutamine) as the minor N-terminal group. These au- 
thors also suspected phenylalanine to be the C-termi- 
nal amino acid corresponding to the N-terminal 
glycine. Our results confirm their assessment. 
The present results on human P7 proteolipid apo- 
protein do not allow to detect any differences with 
that originating from rat brain; this would most 
probably indicate that the structure of this protein 
has been stable during evolution as did myelin basic 
proteins where only 11 amino acids substitutions 
were observed between the human and the bovine 
proteins [ 111. Nevertheless, definite conclusions can 
only be drawn when the entire sequence is known. 
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